Military Antimicrobial Stewardship: Improving Parenteral Antibiotics Medication Administration in a Malaysian Military Hospital

Abstract

INTRODUCTION. Medication Administration Errors (MAEs) are possible and may cause potentially serious or fatal effect. Parenteral antibiotics medication has particularly been associated with serious and life threatening errors. Ob- jective: The objective of this study was to determine the com- mon types of Medication Administration Errors (MAE) and to improve the rate of Correct Medication Administration (CMA) for parenteral antibiotics. METHODS. The standard set was 100% CMA rate. The indicator was an improvement in the CMA rate (CMA rate = 100% - MAE rate). The un- disguised direct observation was used to evaluate medication administration at two medical wards in a military hospital. One observer who is a pharmacist followed the medication serving rounds and documented the parenteral antibiotics drug preparation and administration. Observation infor- mation was collected at pre and post intervention. During baseline data collection, the perceived contributing factors were documented when there were intervention strategies. RESULTS. At the pre-intervention stage, 284 out of 559 drug administrations observed had at least an error (MAE rate 50.8%, CMA rate 49.2%). The most common error was incorrect drug preparation (32.7%), incorrect admin- istration technique (23.2%), incorrect rate error (19.7%), deteriorated drug error (11.6%) and omission error (3.8%). The common contributing factors were inadequate knowl- edge (46.0%), failure to adhere to guidelines (22.4%) and incomplete guidelines (19.7%). Quick reference guide for parenteral antibiotics was developed. Pharmacist-led educational sessions were conducted to educate nursing staffs on medication safety and the use of the reference guide. At post-intervention-stage, 152 out of 468 drug administra- tion observed had at least an error (MAE rate 32.5%, CMA rate 67.5%). DISCUSSION. Post remedial analysis demonstrated a marked improvement of CMA rate from 49.2% to 67.5%. CONCLUSION. Future strategies should be implemented to further reduce MAEs for all class of medications.

PDF